AI-Designed Logic Gated (AND/OR/NOT) CAR Service

Q: Q1: How does an 'AND' gate improve safety compared to a standard CAR?

An 'AND' gate requires the simultaneous presence of two distinct antigens to trigger T-cell activation. This ensures that the CAR T cells only attack tumor cells expressing both markers, sparing healthy tissues that might express only one. Our AI optimizes the binding kinetics to ensure efficient dual-signal integration.

Q: Q3: What is the benefit of including a 'NOT' gate?

A 'NOT' gate allows the CAR T cell to recognize a safety signal on healthy cells. If the 'NOT' antigen is detected, the T cell is inhibited, preventing 'off-tumor' damage. This is particularly useful for targeting antigens that are overexpressed on tumors but also present on vital organs.

Online Inquiry

Background Service What We Can Offer Workflow Highlights FAQs Contact

Creative Biolabs provides an AI-Designed Logic-Gated (AND/OR/NOT) CARs Service to address key challenges in cell therapy development, including off-tumor toxicity, limited T-cell persistence, and antigen escape in solid tumors. This service enables the design of highly precise and durable smart CAR constructs through advanced computational modeling and deep learning based structural optimization. By incorporating logic-gated targeting strategies, Creative Biolabs enhances tumor specificity and functional control, supporting the development of next-generation cell therapies capable of accurately distinguishing between healthy tissues and complex tumor microenvironments.

Introduction

Logic-gated CAR systems incorporate Boolean logic (AND, OR, NOT) into engineered immune cells to enable conditional activation and improved targeting precision. Recent studies demonstrate that multi-antigen recognition strategies significantly enhance tumor selectivity while reducing toxicity. Advances in computational biology and synthetic gene circuits have further enabled the rational design of programmable CAR systems. These developments position AI-assisted logic-gated CAR design as a critical approach for next-generation cell therapies.

Service

Creative Biolabs provides a comprehensive computational pipeline to design and validate "smart" CAR T cells capable of processing multiple signals. By implementing Boolean logic, AND, OR, and NOT gates, we enable your therapeutic candidates to perform real-time decision-making, significantly reducing toxicities and overcoming the heterogeneity of solid tumors.

Our key capabilities center on advanced CAR-T and logic-gated cellular therapy design: we optimize target antigen combinations for AND/OR/NOT gating using tumor specificity and expression profiles, engineer tailored CAR architectures including dual, tandem, inhibitory, and inducible systems, model Boolean logic circuits to predict activation thresholds in heterogeneous tumors, implement NOT‑gate strategies for enhanced safety and reduced off‑tumor toxicity, and apply AI‑driven models to forecast cytotoxicity, persistence, and T‑cell exhaustion risk.

Discover How We Can Help - Request a Consultation.

What We Can Offer

Multi-Antigen Target Discovery	CAR Design & Engineering Platforms
Integration of transcriptomic and proteomic datasets to identify tumor-specific antigen combinations AI-driven selection of optimal AND/OR/NOT logic configurations	Dual CAR and tandem CAR design for OR-gate functionality Split signaling CAR systems for AND-gate activation Inhibitory CAR constructs for NOT-gate safety control Modular CAR backbone optimization including hinge, transmembrane, and intracellular domains
Synthetic Gene Circuit Design	In Silico Functional Simulation
Programmable receptor systems for inducible CAR expression Multi-layer gene circuits enabling complex logic operations Tunable activation thresholds through computational modeling	Tumor heterogeneity modeling and antigen distribution simulation CAR activation dynamics and signaling strength prediction Exhaustion and persistence risk analysis
Safety & Specificity Optimization
Cross-reactivity prediction Off-target risk assessment Cytokine release potential modeling

Our Workflow

To initiate the project, clients typically provide target antigen profiles, preferred scFv sequences or epitope data, and specific clinical constraints such as desired signaling domains.

Workflow of AI-Designed Logic Gated (AND/OR/NOT) CARs Service. (Creative Biolabs Original)

Final Deliverables: Clients receive a detailed Computational Optimization Report (including molecular dynamics and docking scores), the Validated Genetic Sequences of the logic-gated constructs, and a Functional Performance Data Package demonstrating specificity and cytotoxicity.

Core Benefits

Customized Logic Architecture: Bespoke design of AND, OR, and NOT gates tailored to your specific tumor-associated antigen profiles.
AI-Guided Humanization: Proprietary pipelines to humanize murine-derived scFvs while maintaining maximal binding affinity and reducing immunogenicity.
Structural Self-Interference Screening: Molecular dynamics simulations to ensure multi-scFv designs do not suffer from steric hindrance or self-activation.
Metabolic & Persistence Engineering: Integration of AI-designed modules for targeted protein degradation to enhance T-cell memory.

FAQs

Q1: How does an "AND" gate improve safety compared to a standard CAR?

A1: An "AND" gate requires the simultaneous presence of two distinct antigens to trigger T-cell activation. This ensures that the CAR T cells only attack tumor cells expressing both markers, sparing healthy tissues that might express only one. Our AI optimizes the binding kinetics to ensure efficient dual-signal integration.

Q2: Can you design logic gates for targets we have already identified?

A2: Our service is highly customized. We can take your existing scFv sequences and use our AI platform to determine the optimal orientation, hinge length, and logic configuration to maximize their therapeutic index.

Q3: What is the benefit of including a "NOT" gate?

A3: A "NOT" gate allows the CAR T cell to recognize a safety signal on healthy cells. If the "NOT" antigen is detected, the T cell is inhibited, preventing "off-tumor" damage. This is particularly useful for targeting antigens that are overexpressed on tumors but also present on vital organs.

Q4: How does AI help in preventing CAR T-cell exhaustion?

A4: Our AI models predict tonic signaling and self-activation, two primary drivers of exhaustion. By optimizing the structural stability of the CAR, we reduce chronic signaling, while our metabolic engineering modules promote a long-lived memory phenotype.

Partner with Us

Creative Biolabs provides a world-class AI-Designed Logic Gated (AND/OR/NOT) CARs Service that transforms conventional cell therapies into intelligent, decision-making therapeutic agents. By integrating deep learning, structural biology, and metabolic reprogramming, we address critical challenges in modern oncology, including on-target off-tumor toxicity and limited therapeutic persistence. Our end-to-end solutions support rational CAR design, safety optimization, and in silico performance prediction to accelerate the development of next-generation CAR-T products. Contact our team to discuss your project and explore customized solutions.

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.